Use of Cystatin C Biomarker in Patients with Possible Renal Failure

Renal injury is a frequent complication in hospitalized and outpatients and its incidence has increased in recent years, either as a primary disease or as a secondary diagnosis. Early detection of kidney disease in its milder degree would be beneficial to begin treatment for better results. This lit...

Full description

Bibliographic Details
Main Authors: Alexander Benavides Couto, Yamila Rodríguez Jiménez, Dellys González Borges, Idalmis Luisa Martinez Serrano, Ibis Hernandez Palet, Belkis Rosa Vilaboy Perez
Format: Article
Language:Spanish
Published: Universidad de las Ciencias Médicas de Cienfuegos 2019-11-01
Series:Revista Finlay
Subjects:
Online Access:http://revfinlay.sld.cu/index.php/finlay/article/view/717
id doaj-2d7f9a262ecf4c668a85878f6f464c45
record_format Article
spelling doaj-2d7f9a262ecf4c668a85878f6f464c452020-11-25T03:37:51ZspaUniversidad de las Ciencias Médicas de CienfuegosRevista Finlay2221-24342019-11-0194306313422Use of Cystatin C Biomarker in Patients with Possible Renal FailureAlexander Benavides Couto0Yamila Rodríguez Jiménez1Dellys González Borges2Idalmis Luisa Martinez Serrano3Ibis Hernandez Palet4Belkis Rosa Vilaboy Perez5Universidad de Ciencias Medicas. Cienfuegos.Universidad de Ciencias Medicas. Cienfuegos.Universidad de Ciencias Medicas. Cienfuegos.Universidad de Ciencias Medicas. Cienfuegos.Universidad de Ciencias Medicas. Cienfuegos.Universidad de Ciencias Medicas.Cienfuegos.Renal injury is a frequent complication in hospitalized and outpatients and its incidence has increased in recent years, either as a primary disease or as a secondary diagnosis. Early detection of kidney disease in its milder degree would be beneficial to begin treatment for better results. This literature review, based on the analysis of about 30 scientific articles, describes the feasibility of using cystatin C as a renal biomarker; it also refers to the advantages and limitations that its use reports within the clinical bioanalysis; and finally the importance of the future use of cystatin C as an analytical biomarker in different laboratories of the health system in Cienfuegos. This work provides relevant information about health personnel´s updating and training in medical conditions which may be detected at the molecular and cellular level.http://revfinlay.sld.cu/index.php/finlay/article/view/717cistatina cenfermedades renaleslaboratoriocapacitación profesionalsalud pública
collection DOAJ
language Spanish
format Article
sources DOAJ
author Alexander Benavides Couto
Yamila Rodríguez Jiménez
Dellys González Borges
Idalmis Luisa Martinez Serrano
Ibis Hernandez Palet
Belkis Rosa Vilaboy Perez
spellingShingle Alexander Benavides Couto
Yamila Rodríguez Jiménez
Dellys González Borges
Idalmis Luisa Martinez Serrano
Ibis Hernandez Palet
Belkis Rosa Vilaboy Perez
Use of Cystatin C Biomarker in Patients with Possible Renal Failure
Revista Finlay
cistatina c
enfermedades renales
laboratorio
capacitación profesional
salud pública
author_facet Alexander Benavides Couto
Yamila Rodríguez Jiménez
Dellys González Borges
Idalmis Luisa Martinez Serrano
Ibis Hernandez Palet
Belkis Rosa Vilaboy Perez
author_sort Alexander Benavides Couto
title Use of Cystatin C Biomarker in Patients with Possible Renal Failure
title_short Use of Cystatin C Biomarker in Patients with Possible Renal Failure
title_full Use of Cystatin C Biomarker in Patients with Possible Renal Failure
title_fullStr Use of Cystatin C Biomarker in Patients with Possible Renal Failure
title_full_unstemmed Use of Cystatin C Biomarker in Patients with Possible Renal Failure
title_sort use of cystatin c biomarker in patients with possible renal failure
publisher Universidad de las Ciencias Médicas de Cienfuegos
series Revista Finlay
issn 2221-2434
publishDate 2019-11-01
description Renal injury is a frequent complication in hospitalized and outpatients and its incidence has increased in recent years, either as a primary disease or as a secondary diagnosis. Early detection of kidney disease in its milder degree would be beneficial to begin treatment for better results. This literature review, based on the analysis of about 30 scientific articles, describes the feasibility of using cystatin C as a renal biomarker; it also refers to the advantages and limitations that its use reports within the clinical bioanalysis; and finally the importance of the future use of cystatin C as an analytical biomarker in different laboratories of the health system in Cienfuegos. This work provides relevant information about health personnel´s updating and training in medical conditions which may be detected at the molecular and cellular level.
topic cistatina c
enfermedades renales
laboratorio
capacitación profesional
salud pública
url http://revfinlay.sld.cu/index.php/finlay/article/view/717
work_keys_str_mv AT alexanderbenavidescouto useofcystatincbiomarkerinpatientswithpossiblerenalfailure
AT yamilarodriguezjimenez useofcystatincbiomarkerinpatientswithpossiblerenalfailure
AT dellysgonzalezborges useofcystatincbiomarkerinpatientswithpossiblerenalfailure
AT idalmisluisamartinezserrano useofcystatincbiomarkerinpatientswithpossiblerenalfailure
AT ibishernandezpalet useofcystatincbiomarkerinpatientswithpossiblerenalfailure
AT belkisrosavilaboyperez useofcystatincbiomarkerinpatientswithpossiblerenalfailure
_version_ 1724543404267798528